Double-Punch combo trial aims to tame aggressive cancer
Disease control
Recruiting now
This study is testing a two-part treatment for Richter's syndrome, an aggressive cancer that develops from a slower-growing blood cancer. It combines a daily pill (zanubrutinib) with a one-time infusion of specially modified immune cells (CAR-T therapy) to attack the cancer. The …
Phase: PHASE2 • Sponsor: Aseel Alsouqi • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC